Cargando…

Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL (TM))

Resveratrol exhibits a wide range of biological properties, including anti-glycation, antioxidant, anti-inflammation, neuroprotective (including against advanced dementia and Alzheimer’s disease), anti-cancer, and anti-aging activity in experimental models (Galiniak et al., Acta Biochim Pol 66:13-21...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kemper, Christopher, Behnam, Dariush, Brothers, Shaun, Wahlestedt, Claes, Volmar, Claude-Henry, Bennett, Daniel, Hayward, Marshall
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243782/ https://www.ncbi.nlm.nih.gov/pubmed/35789594 http://dx.doi.org/10.1186/s41120-022-00058-1

Ejemplares similares

Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients
por: Dennison, Jessica L., et al.
Publicado: (2022)

Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma
por: Lohse, Ines, et al.
Publicado: (2018)

Inhibition of HDAC3 reverses Alzheimer’s disease-related pathologies in vitro and in the 3xTg-AD mouse model
por: Janczura, Karolina J., et al.
Publicado: (2018)

HDAC Inhibitors Induce BDNF Expression and Promote Neurite Outgrowth in Human Neural Progenitor Cells-Derived Neurons
por: Bagheri, Amir, et al.
Publicado: (2019)

Therapeutic potential of neuropeptide Y (NPY) receptor ligands
por: Brothers, Shaun P, et al.
Publicado: (2010)

Nucleic acid-based therapeutics for the treatment of central nervous system disorders
por: McCartan, Robyn, et al.
Publicado: (2023)

Amplifying gene expression with RNA-targeted therapeutics
por: Khorkova, Olga, et al.
Publicado: (2023)

Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer
por: Mustafi, Sushmita, et al.
Publicado: (2019)

Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research
por: Dennison, Jessica L., et al.
Publicado: (2021)

Natural antisense transcripts as drug targets
por: Khorkova, Olga, et al.
Publicado: (2022)

Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD Mouse
por: Dennison, Jessica, et al.
Publicado: (2023)

Emerging treatment strategies for glioblastoma multiforme
por: Carlsson, Steven K, et al.
Publicado: (2014)

BET bromodomain proteins are required for glioblastoma cell proliferation
por: Pastori, Chiara, et al.
Publicado: (2014)

Precision medicine in the treatment stratification of AML patients: challenges and progress
por: Lohse, Ines, et al.
Publicado: (2018)

Oxytocin and social functioning
por: Jones, Candace, et al.
Publicado: (2017)

A Novel RNA Transcript with Antiapoptotic Function Is Silenced in Fragile X Syndrome
por: Khalil, Ahmad M., et al.
Publicado: (2008)

The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer’s Disease
por: Magistri, Marco, et al.
Publicado: (2016)

M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer’s disease genes and improving memory
por: Volmar, Claude-Henry, et al.
Publicado: (2017)

Preparation of Solid Dispersion of Polygonum Cuspidatum Extract by Hot Melt Extrusion to Enhance Oral Bioavailability of Resveratrol
por: Fan, Wenling, et al.
Publicado: (2023)

The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models
por: Aziz, Abdul Maruf Asif, et al.
Publicado: (2016)

Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol
por: Chimento, Adele, et al.
Publicado: (2019)

Strategies to Improve Resveratrol Systemic and Topical Bioavailability: An Update
por: Intagliata, Sebastiano, et al.
Publicado: (2019)

Enhancing Bioavailability of Nutraceutically Used Resveratrol and Other Stilbenoids
por: Vesely, Ondrej, et al.
Publicado: (2021)

Enhanced Oral Bioavailability of Resveratrol by Using Neutralized Eudragit E Solid Dispersion Prepared via Spray Drying
por: Ha, Eun-Sol, et al.
Publicado: (2021)

A novel knockout mouse model of the noncoding antisense Brain-Derived Neurotrophic Factor (Bdnf) gene displays increased endogenous Bdnf protein and improved memory function following exercise
por: Modarresi, Farzaneh, et al.
Publicado: (2021)

Comparative pharmacokinetics of new curcumin preparations and evidence for increased bioavailability in healthy adult participants
por: Hirose, Akiko, et al.
Publicado: (2022)

Impact of a High-Fat Meal and Sprinkled Administration on the Bioavailability and Pharmacokinetics of Viloxazine Extended-Release Capsules (Qelbree(TM)) in Healthy Adult Subjects
por: Wang, Zhao, et al.
Publicado: (2021)

Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer’s Disease Models
por: Ricciardi, Natalie R., et al.
Publicado: (2023)

Increased Oral Bioavailability of Resveratrol by Its Encapsulation in Casein Nanoparticles
por: Peñalva, Rebeca, et al.
Publicado: (2018)

Determination of Quercetin and Resveratrol in Whole Blood—Implications for Bioavailability Studies
por: Biasutto, Lucia, et al.
Publicado: (2010)

A Brief Updated Review of Advances to Enhance Resveratrol’s Bioavailability
por: de Vries, Konrad, et al.
Publicado: (2021)

Resveratrol loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles for tail vein injection II: pharmacokinetics, tissue distribution and bioavailability
por: Wu, Mingfang, et al.
Publicado: (2019)

Bioavailability and pharmacokinetics of oral meloxicam in llamas
por: Kreuder, Amanda J, et al.
Publicado: (2012)

Pharmacokinetics, bioavailability, and excretion of ponazuril in piglets
por: Wang, Wenxiang, et al.
Publicado: (2022)

A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease
por: Timmons, James A, et al.
Publicado: (2022)

Resveratrol Supported on Magnesium DiHydroxide (Resv@MDH) Represents an Oral Formulation of Resveratrol With Better Gastric Absorption and Bioavailability Respect to Pure Resveratrol
por: Iannitti, Rossana Giulietta, et al.
Publicado: (2020)

Enhancing the Delivery of Resveratrol in Humans: If Low Bioavailability is the Problem, What is the Solution?
por: Smoliga, James M., et al.
Publicado: (2014)

Longevity‐related molecular pathways are subject to midlife “switch” in humans
por: Timmons, James A., et al.
Publicado: (2019)

Trans-Resveratrol Oral Bioavailability in Humans Using LipiSperse™ Dispersion Technology
por: Briskey, David, et al.
Publicado: (2020)

Transcriptomics for Clinical and Experimental Biology Research: Hang on a Seq
por: Stokes, Tanner, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6imm17p7rg6d9vqspen2sf7m0t